Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Inogen Inc. buy melinda

Start price
€191.04
16.10.18 / 50%
Target price
€225.50
08.11.18
Performance (%)
-28.00%
End price
€137.55
08.11.18
Summary
This prediction ended on 08.11.18 with a price of €137.55. The prediction for Inogen Inc. disappointed with a performance of -28.00%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Inogen Inc. 9.000% 9.000% 92.920% -79.815%
iShares Core DAX® 2.821% -1.953% 15.071% 11.862%
iShares Nasdaq 100 5.285% -5.092% 29.254% 40.075%
iShares Nikkei 225® 3.687% -4.221% 14.286% 6.629%
iShares S&P 500 3.577% -2.240% 25.546% 38.398%

Comments by melinda for this prediction

In the thread Inogen Inc. diskutieren
Prediction Buy
Perf. (%) -28.00%
Target price 225.500
Change
Ends at 08.11.18

SecteurEquipement, fournitures et distribution médicale Agenda 06/11 Publication de résultats



Métier
Operates as a medical technology company

Inogen, Inc . engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G2 system, and Inogen at Home.

The company was founded by Alison Perry, Alison Bauerlein, Brenton Taylor and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.

Nombre d'employés : 770 personnes.



Prediction Buy
Perf. (%) -28.00%
Target price 225.500
Change
Ends at 08.11.18

(Vom Mitglied beendet)

Stopped prediction by melinda for Inogen Inc.

buy
Inogen Inc.

Start price
Target price
Perf. (%)
€86.56
31.03.19
€108.24
04.11.21
-61.19%
21.12.20